Selvita S.A. (SLV)
GPW
Closed
Oct 8, 2026
Day's Range
21.7552 wk Range
20.20Overview - SLV - Selvita S.A.
Key Statistics
Valuation
Enterprise Value
562.50M
P/E (Trailing)
‪762.50‬
P/E (Forward)
‪29.19‬
PEG Ratio
‪1.52‬
Price / Sales (TTM)
‪1.12‬
Price / Book
‪1.23‬
EV / EBITDA
‪14.69‬
Profitability
Gross Margin
‪78.05%‬
Profit Margin
‪-0.59%‬
Operating Margin
‪-0.80%‬
Return on Assets
‪0.85%‬
Return on Equity
‪-0.66%‬
Ownership
Shares Outstanding
18.35M
Float
9.74M
Held by Insiders
‪21.18%‬
Held by Institutions
‪27.33%‬
Price stats
Beta
‪0.08‬
50-Day Avg
‪26.39‬
200-Day Avg
‪34.17‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪PLN 39.27‬Market Cap - SLV - Selvita S.A.
Peers - SLV - Selvita S.A.
Peer Comparison
Compared with companies in Diagnostics & Research listed on GPW.
Profile Summary - SLV - Selvita S.A.
About
Selvita S.A. is a leading biotechnology company that focuses on providing comprehensive drug discovery services. Established in Kraków, Poland, Selvita operates in the dynamic field of life sciences, primarily gearing its efforts toward accelerating the development of therapies through innovative research and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
